European Surgery

, Volume 50, Issue 5, pp 232–236 | Cite as

Efficacy of laparoscopic hepatectomy in patients with liver cirrhosis

  • Yusuke Ome
  • Kazuki Hashida
  • Mitsuru Yokota
  • Yoshio Nagahisa
  • Michio Okabe
  • Kazuyuki Kawamoto
original article



Hepatectomy in patients with liver cirrhosis is associated with a higher rate of complications. The purpose of this study was to evaluate the efficacy of laparoscopic hepatectomy in cirrhotic patients.


We introduced laparoscopic hepatectomy in our institution in April 2014. We performed 53 procedures on patients with cirrhosis from April 2014 to May 2017. Open hepatectomy was performed on 68 patients with cirrhosis from January 2010 to May 2017. This study retrospectively analyzed and compared the patient characteristics, perioperative factors, and short-term outcomes in the two groups.


There were no conversions to open surgery in the laparoscopic hepatectomy group. With respect to patient characteristics, this group had significantly higher body mass index (p < 0.001), more patients with a past history of abdominal surgery (p < 0.021), and more patients with a past history of transarterial chemoembolization or radiofrequency ablation (p = 0.006). Regarding the short-term outcomes, the operation times were comparable (p = 0.709). The laparoscopic hepatectomy group had less blood loss (median 5 ml vs. 449.5 ml; p < 0.001), lower rate of intraoperative transfusions (1.9% vs. 22.1%; p = 0.001), and shorter postoperative hospital stays (median 7 days vs. 10 days; p < 0.001). The other results, including severe postoperative complications and mortality, were comparable.


Laparoscopic hepatectomy is a useful and viable option in patients with cirrhosis.


Laparoscopic hepatectomy Open hepatectomy Laparoscopic liver resection Liver cirrhosis Anatomic resection 


Compliance with ethical guidelines

Conflict of interest

Y. Ome, K. Hashida, M. Yokota, Y. Nagahisa, M. Okabe, and K. Kawamoto declare that they have no competing interests.

Ethical standards

This retrospective study was reviewed and approved by the Institution Review Board of Kurashiki Central Hospital. Patients were not required to give informed consent to this study because the analysis used anonymous clinical data that were obtained after each patient agreed to treatment by written consent.


  1. 1.
    Farges O, Malassagne B, Flejou JF, Balzan S, Sauvanet A, Belghiti J. Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal. Ann Surg. 1999;229(2):210–5.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Buell JF, Thomas MT, Rudich S, Marvin M, Nagubandi R, Ravindra KV, et al. Experience with more than 500 minimally invasive hepatic procedures. Ann Surg. 2008;248(3):475–86.PubMedGoogle Scholar
  3. 3.
    Kaneko H, Takagi S, Otsuka Y, Tsuchiya M, Tamura A, Katagiri T, et al. Laparoscopic liver resection of hepatocellular carcinoma. Am J Surg. 2005;189(2):190–4.CrossRefPubMedGoogle Scholar
  4. 4.
    Kazaryan AM, Pavlik Marangos I, Rosseland AR, Rosok BI, Mala T, Villanger O, et al. Laparoscopic liver resection for malignant and benign lesions: ten-year Norwegian single-center experience. Arch Surg. 2010;145(1):34–40.CrossRefPubMedGoogle Scholar
  5. 5.
    Nguyen KT, Gamblin TC, Geller DA. World review of laparoscopic liver resection-2,804 patients. Ann Surg. 2009;250(5):831–41.CrossRefPubMedGoogle Scholar
  6. 6.
    Sasaki A, Nitta H, Otsuka K, Takahara T, Nishizuka S, Wakabayashi G. Ten-year experience of totally laparoscopic liver resection in a single institution. Br J Surg. 2009;96(3):274–9.CrossRefPubMedGoogle Scholar
  7. 7.
    Makuuchi M, Kosuge T, Takayama T, Yamazaki S, Kakazu T, Miyagawa S, et al. Surgery for small liver cancers. Semin Surg Oncol. 1993;9(4):298–304.CrossRefPubMedGoogle Scholar
  8. 8.
    Ichida F, Tsuji T, Omata M, Ichida T, Inoue K, Kamimura T, et al. New inuyama classification; new criteria for histological assessment of chronic hepatitis. Int Hepatol Commun. 1996;6(2):112–9.CrossRefGoogle Scholar
  9. 9.
    Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology. 1996;24(2):289–93.CrossRefPubMedGoogle Scholar
  10. 10.
    Kanazawa A, Tsukamoto T, Shimizu S, Kodai S, Yamazoe S, Yamamoto S, et al. Impact of laparoscopic liver resection for hepatocellular carcinoma with F4-liver cirrhosis. Surg Endosc. 2013;27(7):2592–7.CrossRefPubMedGoogle Scholar
  11. 11.
    Yamashita Y, Ikeda T, Kurihara T, Yoshida Y, Takeishi K, Itoh S, et al. Long-term favorable surgical results of laparoscopic hepatic resection for hepatocellular carcinoma in patients with cirrhosis: a single-center experience over a 10-year period. J Am Coll Surg. 2014;219(6):1117–23.CrossRefPubMedGoogle Scholar
  12. 12.
    Cheung TT, Dai WC, Tsang SH, Chan AC, Chok KS, Chan SC, et al. Pure laparoscopic hepatectomy versus open hepatectomy for hepatocellular carcinoma in 110 patients with liver cirrhosis: a propensity analysis at a single center. Ann Surg. 2016;264(4):612–20.CrossRefPubMedGoogle Scholar
  13. 13.
    Belli G, Limongelli P, Fantini C, D’Agostino A, Cioffi L, Belli A, et al. Laparoscopic and open treatment of hepatocellular carcinoma in patients with cirrhosis. Br J Surg. 2009;96(9):1041–8.CrossRefPubMedGoogle Scholar
  14. 14.
    Memeo R, de’Angelis N, Compagnon P, Salloum C, Cherqui D, Laurent A, et al. Laparoscopic vs. open liver resection for hepatocellular carcinoma of cirrhotic liver: a case-control study. World J Surg. 2014;38(11):2919–26.CrossRefPubMedGoogle Scholar
  15. 15.
    Yoon YI, Kim KH, Kang SH, Kim WJ, Shin MH, Lee SK, et al. Pure laparoscopic versus open right hepatectomy for hcarcinoma in patients with cirrhosis: a propensity score matched analysis. Ann Surg. 2017;265(5):856–63.CrossRefPubMedGoogle Scholar
  16. 16.
    Komorizono Y, Oketani M, Sako K, Yamasaki N, Shibatou T, Maeda M, et al. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation. Cancer. 2003;97(5):1253–62.CrossRefPubMedGoogle Scholar
  17. 17.
    Barcelona Liver Cancer Group, Llovet JM, Real MI, Montana X, Planas R, Coll S, Aponte J, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet. 2002;359(9319):1734–9.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Austria, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of SurgeryKurashiki Central HospitalKurashikiJapan

Personalised recommendations